Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:DNP NYSEAMERICAN:FAX NASDAQ:IBB OTCMKTS:PSHZF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDNPDNP Select Income Fund$9.79+0.5%$9.73$8.63▼$10.04$3.62B0.31628,745 shs432,932 shsFAXabrdn Asia-Pacific Income Fund$16.00+0.3%$15.80$13.99▼$17.55$3.96B0.59145,954 shs159,389 shsIBBiShares Biotechnology ETF$129.73-1.5%$126.09$107.43▼$150.57$5.26B0.731.46 million shs1.11 million shsPSHZFPershing Square$56.53+1.0%$53.28$40.35▼$57.85$10.34B1.1624,584 shs14,511 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDNPDNP Select Income Fund0.00%+0.98%+1.50%+3.54%+13.84%FAXabrdn Asia-Pacific Income Fund0.00%-0.68%+1.33%+6.60%+4.83%IBBiShares Biotechnology ETF0.00%-1.41%+3.15%+9.67%-11.37%PSHZFPershing Square0.00%+0.69%+7.67%+23.70%+4.66%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDNPDNP Select Income FundN/AN/AN/AN/AN/AN/AN/AN/AFAXabrdn Asia-Pacific Income FundN/AN/AN/AN/AN/AN/AN/AN/AIBBiShares Biotechnology ETFN/AN/AN/AN/AN/AN/AN/AN/APSHZFPershing Square0.2654 of 5 stars0.03.00.80.00.00.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDNPDNP Select Income Fund 0.00N/AN/AN/AFAXabrdn Asia-Pacific Income Fund 0.00N/AN/AN/AIBBiShares Biotechnology ETF 2.67Moderate Buy$129.73N/APSHZFPershing Square 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDNPDNP Select Income FundN/AN/AN/AN/AN/AN/AFAXabrdn Asia-Pacific Income FundN/AN/AN/AN/AN/AN/AIBBiShares Biotechnology ETFN/AN/AN/AN/AN/AN/APSHZFPershing Square$238.90M43.29$6.42 per share8.81$71.12 per share0.79Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDNPDNP Select Income FundN/AN/A0.00∞N/AN/AN/AN/AN/AFAXabrdn Asia-Pacific Income FundN/AN/A0.00∞N/AN/AN/AN/AN/AIBBiShares Biotechnology ETFN/AN/A0.00∞N/AN/AN/AN/AN/APSHZFPershing Square$1.17BN/A0.00∞N/AN/AN/AN/A8/13/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDNPDNP Select Income Fund$0.787.97%N/AN/AN/AFAXabrdn Asia-Pacific Income Fund$1.9812.38%N/AN/AN/AIBBiShares Biotechnology ETF$0.380.29%N/AN/AN/APSHZFPershing Square$0.661.17%N/AN/AN/ALatest PSHZF, IBB, FAX, and DNP DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/17/2025DNPDNP Select Income Fundmonthly$0.06508.1%9/30/20259/30/202510/10/20256/18/2025DNPDNP Select Income Fundmonthly$0.06508.1%9/30/20259/30/202510/10/20256/18/2025DNPDNP Select Income Fundmonthly$0.06508.1%8/29/20258/29/20259/10/20256/16/2025DNPDNP Select Income Fundjul 25$0.06508.1%7/31/20257/31/20258/11/20257/11/2025FAXabrdn Asia-Pacific Income Fundmonthly$0.165012.3%7/24/20257/24/20257/31/20256/11/2025FAXabrdn Asia-Pacific Income Fundmonthly$0.165012.6%6/23/20256/23/20256/30/20255/16/2025PSHZFPershing Square$0.16461.31%5/16/20255/19/20256/20/20255/24/2025DNPDNP Select Income Fund$0.06508%5/30/20256/2/20256/10/20255/13/2025FAXabrdn Asia-Pacific Income Fundmonthly$0.165012.6%5/22/20255/22/20255/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDNPDNP Select Income FundN/AN/AN/AFAXabrdn Asia-Pacific Income FundN/AN/AN/AIBBiShares Biotechnology ETFN/AN/AN/APSHZFPershing Square0.182.012.01Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDNPDNP Select Income Fund8.51%FAXabrdn Asia-Pacific Income Fund33.55%IBBiShares Biotechnology ETF62.45%PSHZFPershing Square0.03%Insider OwnershipCompanyInsider OwnershipDNPDNP Select Income Fund0.06%FAXabrdn Asia-Pacific Income Fund1.00%IBBiShares Biotechnology ETFN/APSHZFPershing SquareN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDNPDNP Select Income Fund590370.03 million369.81 millionNot OptionableFAXabrdn Asia-Pacific Income FundN/A247.70 million245.22 millionNot OptionableIBBiShares Biotechnology ETFN/A40.55 millionN/AOptionablePSHZFPershing SquareN/A182.96 millionN/ANot OptionablePSHZF, IBB, FAX, and DNP HeadlinesRecent News About These CompaniesPershing Square (OTCMKTS:PSHZF) Stock Passes Above 50 Day Moving Average - What's Next?July 15, 2025 | marketbeat.comBill Ackman falls short in pro tennis debut at Hall of Fame OpenJuly 9, 2025 | msn.comPershing Square (OTCMKTS:PSHZF) Shares Gap Down - Should You Sell?July 8, 2025 | marketbeat.comPershing Square (OTCMKTS:PSHZF) Stock Price Passes Above 50-Day Moving Average - Time to Sell?June 27, 2025 | marketbeat.comPershing Square Commences $200M Share BuybackJune 26, 2025 | marketwatch.comBill Ackman opens up on investing, activism, Harvard... and Brad PittJune 8, 2025 | msn.comBill Ackman Is Killing It. A New ETF Will Track His Investments.May 30, 2025 | msn.comBillionaire Bill Ackman just added this ‘800-pound gorilla’ to his FTSE 100-listed fundMay 27, 2025 | msn.comQ1 2025 Pershing Square Holdings Ltd Earnings CallMay 24, 2025 | uk.finance.yahoo.comBill Ackman’s Pershing Square sells CPKC stake, makes Amazon investmentMay 23, 2025 | theglobeandmail.comAmazon gains after Bill Ackman's Pershing Square discloses a new stakeMay 23, 2025 | msn.comPershing Square Holdings, Ltd. (PSHZF) Q1 2025 Earnings Call TranscriptMay 22, 2025 | seekingalpha.comBill Ackman's Pershing Square Buys $2.2B of Uber and Hertz Shares in Q1, Dumps NikeMay 20, 2025 | ibtimes.co.ukIPershing Square chief leaves Universal Music chair for Howard HughesMay 15, 2025 | lse.co.ukPershing Square Founder Bill Ackman Resigns From UMG’s BoardMay 15, 2025 | billboard.comBPershing Square Holdings, Ltd. Notes New Time for First Quarter 2025 Investor CallMay 12, 2025 | gurufocus.comPershing Square Holdings, Ltd. Notes New Time for First Quarter 2025 Investor CallMay 12, 2025 | businesswire.comPershing Square Holdings, Ltd. Announces First Quarter 2025 Investor CallMay 10, 2025 | uk.finance.yahoo.comBill Ackman's Pershing Square invests USD900 million in Howard HughesMay 6, 2025 | lse.co.ukBill Ackman’s hedge fund just got closer to buying up downtown Columbia developerMay 5, 2025 | thebaltimorebanner.comTBill Ackman's Pershing Square Boosts Howard Hughes Stake with $900 Million InvestmentMay 5, 2025 | sohu.comSNew MarketBeat Followers Over TimeMedia Sentiment Over TimePSHZF, IBB, FAX, and DNP Company DescriptionsDNP Select Income Fund NYSE:DNP$9.79 +0.05 (+0.51%) Closing price 07/18/2025 03:59 PM EasternExtended Trading$9.76 -0.03 (-0.31%) As of 07/18/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DNP Select Income Fund Inc. is a closed ended balanced mutual fund launched by Virtus Investment Partners, Inc. The fund is managed by Duff & Phelps Investment Management Co. It invests in the public equity and fixed income markets of the United States. For the fixed income portion, the fund invests in bonds. It seeks to invest in stocks of companies operating in the Utility sector. The fund invests in stocks of companies across all market capitalizations. It benchmarks the performance of its portfolio against the S&P 500 Utilities Index and Barclays Capital U.S. Utility Bond Index. DNP Select Income Fund Inc. was formed on November 26, 1986 and is domiciled in the United States.abrdn Asia-Pacific Income Fund NYSEAMERICAN:FAX$16.00 +0.05 (+0.31%) Closing price 07/18/2025 04:10 PM EasternExtended Trading$15.96 -0.04 (-0.22%) As of 07/18/2025 05:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Abrdn Asia-Pacific Income Fund Inc is a close ended fixed income mutual fund launched and managed by Aberdeen Standard Investments (Asia) Limited. It is co-managed by Aberdeen Standard Investments Australia Limited and Aberdeen Asset Managers Limited. The fund invests in fixed income markets of Asia, Australia, and New Zeland. It primarily invests in debt securities issued by governmental entities, banks, companies, and other entities. Abrdn Asia-Pacific Income Fund Inc was formed on March 14, 1986 and is domiciled in the United States.iShares Biotechnology ETF NASDAQ:IBB$129.73 -2.01 (-1.53%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$130.29 +0.56 (+0.43%) As of 07/18/2025 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.Pershing Square OTCMKTS:PSHZF$56.53 +0.58 (+1.03%) As of 07/18/2025 03:13 PM EasternPershing Square Holdings, Ltd. is a closed-ended balanced fund launched and managed by Pershing Square Capital Management, L.P. It invests in public equity and fixed income markets across the globe. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in value stocks of companies. For its fixed income portion, the fund primarily invests in convertible securities and debt securities. It also invests through derivatives. The fund employs long/short strategy to create its portfolio. It benchmarks the performance of its portfolio against the S&P 500 Index and HFRX Global Hedge Fund Index. Pershing Square Holdings, Ltd. was formed on February 2, 2012 and is domiciled in Guernsey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/14 - 07/18 Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
